InsiderFlow

BEN-MAIMON CAROLE

LRMR

BEN-MAIMON CAROLE serves as director, officer: President and CEO at Larimar Therapeutics, Inc. (LRMR). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

3 trades

$168.5K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$168.5K

Companies Traded

1

LRMR

Active Period

Sep 2022 – Nov 2026

3 total trades

Most Recent

Buy LRMR

Nov 12, 2026 · $50.0K

BEN-MAIMON CAROLE's Insider Trading at Larimar Therapeutics, Inc. (LRMR)

Buys

3 · $168.5K

Sells

0 · $0.00

Total Shares Bought

54,796

Total Shares Sold

0

LRMR Price Chart
Loading chart...
DateTypeValue
Nov 12, 2026 Buy$50.0K
May 18, 2023 Buy$18.5K
Sep 19, 2022 Buy$100.0K